Search

everythinglearnresearchcommunity

for

Search:↓

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

Dogs with dermatomyositis, especially Collies and Shetland Sheepdogs, need better treatments for their skin and muscle inflammation.

Hair loss in young men in Central India is linked to severe heart disease.

Nutrease powder, a high-protein, low-carb supplement, can help manage Polycystic Ovary Syndrome symptoms, regulate periods, improve ovulation, and restore fertility.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Hair changes could indicate neurological diseases and help monitor treatment.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Men with coeliac disease may have hormone imbalances that could affect sexual function, but these can improve with better gut health.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Obese women with PCOS are more likely to have fatty liver disease.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Skin diseases, especially psoriasis, greatly affect people's quality of life, similar to chronic diseases.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Finasteride worsens seizures in epilepsy rats and speeds up epileptogenesis in mice.

Dutasteride is more efficient than finasteride, but individual results vary.

Systemic diseases can cause hair loss, which is often reversible with treatment.